These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12968539)

  • 21. The first steps towards gene therapy for Parkinson's disease.
    Svendsen C
    Lancet Neurol; 2007 Sep; 6(9):754-6. PubMed ID: 17706556
    [No Abstract]   [Full Text] [Related]  

  • 22. Herpes virus-based vectors.
    Efstathiou S; Minson AC
    Br Med Bull; 1995 Jan; 51(1):45-55. PubMed ID: 7767648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral vectors as a tool to model and treat Parkinson's disease.
    Bensadoun JC; Aebischer P
    Wien Klin Wochenschr; 2006 Oct; 118(19-20):568-70. PubMed ID: 17136329
    [No Abstract]   [Full Text] [Related]  

  • 24. [Utilization of herpes simplex virus for human gene and cancer therapies].
    Nishiyama Y; Kawaguchi Y
    Uirusu; 2003 Dec; 53(2):155-62. PubMed ID: 15071954
    [No Abstract]   [Full Text] [Related]  

  • 25. Herpes simplex virus vectors.
    Glorioso J; Bender MA; Fink D; DeLuca N
    Mol Cell Biol Hum Dis Ser; 1995; 5():33-63. PubMed ID: 9532560
    [No Abstract]   [Full Text] [Related]  

  • 26. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
    Geller AI; Keyomarsi K; Bryan J; Pardee AB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
    Price RJ; Fisher DG; Suk JS; Hanes J; Ko HS; Kordower JH
    Mov Disord; 2019 Sep; 34(9):1279-1282. PubMed ID: 30908781
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells.
    Vile RG; Diaz RM; Castleden S; Chong H
    Biochem Soc Trans; 1997 May; 25(2):717-22. PubMed ID: 9191190
    [No Abstract]   [Full Text] [Related]  

  • 30. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
    Geller AI; Yu L; Wang Y; Fraefel C
    Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors.
    Ozawa K; Fan DS; Shen Y; Muramatsu S; Fujimoto K; Ikeguchi K; Ogawa M; Urabe M; Kume A; Nakano I
    J Neural Transm Suppl; 2000; (58):181-91. PubMed ID: 11128607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retargeting of herpes simplex virus (HSV) vectors.
    Goins WF; Hall B; Cohen JB; Glorioso JC
    Curr Opin Virol; 2016 Dec; 21():93-101. PubMed ID: 27614209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.
    Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S
    Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic herpes simplex virus for tumor therapy.
    Hu JC; Coffin RS
    Int Rev Neurobiol; 2003; 55():165-84. PubMed ID: 12968536
    [No Abstract]   [Full Text] [Related]  

  • 35. Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
    Advani SJ; Weichselbaum RR; Whitley RJ; Roizman B
    Clin Microbiol Infect; 2002 Sep; 8(9):551-63. PubMed ID: 12427216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.
    Stockhammer G; Brotchi J; Leblanc R; Bernstein M; Schackert G; Weber F; Ostertag C; Mulder NH; Mellstedt H; Seiler R; Yonekawa Y; Twerdy K; Kostron H; De Witte O; Lambermont M; Velu T; Laneuville P; Villemure JG; Rutka JT; Warnke P; Laseur M; Mooij JJ; Boëthius J; Mariani L; Gianella-Borradori A
    J Mol Med (Berl); 1997 Apr; 75(4):300-4. PubMed ID: 9151217
    [No Abstract]   [Full Text] [Related]  

  • 37. Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.
    Mandel RJ; Burger C; Snyder RO
    Exp Neurol; 2008 Jan; 209(1):58-71. PubMed ID: 17916354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of herpes simplex virus in neuroscience.
    Turner SL; Jenkins FJ
    J Neurovirol; 1997 Apr; 3(2):110-25. PubMed ID: 9111174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.
    Glorioso JC; Fink DJ
    Annu Rev Microbiol; 2004; 58():253-71. PubMed ID: 15487938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Herpes simplex virus as a vector for gene therapy].
    Miyatake S
    Uirusu; 1997 Dec; 47(2):239-46. PubMed ID: 9545870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.